icn_podcast
Imaging biomarkers and novel advances in therapies have the potential to revolutionize treatment of neovascular age-related macular degeneration (nAMD) and retinal vascular diseases such as diabetic macular edema (DME) and retinal vein occlusion (RVO). Hear from these experts on how to assess the correlation between imaging biomarkers and functional outcomes in nAMD, DME and RVO and how they are translating this knowledge into individualized treatment decisions for patients. Grantor Statement This